Link revealed between HBV infection and liver cancer

February 17, 2022

Link revealed between HBV infection and liver cancer

HUB Organoids® derived from patients with chronic hepatitis B show the first molecular signs of liver cancer. The molecular events that drive...

read more

CF models for drug development

February 17, 2022

CF models for drug development

HUB Organoids® supports the on-going clinical evaluation of ELX-02 as a therapeutic agent for cystic fibrosis (CF). HUB Organoids advance treatment for...

read more

Test epithelial barrier function

February 17, 2022

Test epithelial barrier function

Discover the development of a new model to assess drug safety, absorption, methabolism, transport, and permeability. Compromised intestinal barrier function has been...

read more

X

Have any questions?

contact us